Recently, an England scholar is in " clinical radiology " on write in a published article, use radio frequency identifies (RFID) label locates alar lymph node is the method of breast cancer treatment with a kind of feasible safety.

By the Hei De that build Ci (England city) the researcher of leader of white queen hospital Dr. Simon Lowes discovers Yi Lisha, be in suffer from make a breast supersonic when be being checked with light of X of double view breast, can have wireless to alar lymph node fixed position through RFID label. Study the group is written. "Current data set conduces to safety of supportive RFID label applying effectively at the fixed position of alar lymph node.

In recent years, people is wireless to using fixed position technology more lymph node of breast cancer of fixed position of choice accurate land is interested more and more. Researcher hypothesis, the problem that the wireless substitute such as RFID label can ease radiative family doctor and surgeon to appear possibly in breast cancer cure, locate lymph node also conduces to patient of help breast cancer formulating better remedial strategy better, avoid excessive cure. Lowes and his colleague notices, about the technology of wireless fixed position of alar lymph node, include but embedded breast detects the use of the RFID label of the area, it is 0 data almost. To increase existing document, they studied use RFID label decides the security of an alar lymph node and feasibility. The passive RFID label that uses 2mm of × of a 11mm already beforehand to load arrives 12 pinhead system (LOCazer, hologic) , this system uses deploy of skin of image guiding classics. Pass next supersonic the placement that affirms label with examination of light of X of double view breast. Every label has an exclusive 5 digit to identify number, read through holding write implement transmit. Read write implement still show the real time between detector and every label is apart from, can arrive accurately millimeter class.

This research still included the data that inserted to alar node to target of before 75 RFID between 2022 2019; During this, be in in all 1, the deploy in 120 patients 1, 296 breasts and alar label (accept new auxiliary RFID label is inserted after the breast cancer patient that turns cure is completing treatment) . These coiling mark is in 11 days on average before the operation embedded. In 75 alar label, 70 show the former breast cancer that send a gender, 5 show without cancer. In the label of 70 clew breast cancer, 20 clew need to undertake new auxiliary change cure. This organization report says, the successful rate of RFID label deploy is 100% . In the meantime, study the group returns discovery, all label and its respective alar lymph node are succeeded purify, without apparent complication. "There is 4 labels shift in excising a process, but as a whole, this does not have those who affect label or lymph node to restore, " Lowes and its work in the same placing are written.

The author of this research suggests, be based on their research achievement, the research data before be united in wedlock, the clinical and professional group that treats female breast cancer should decide to should use technology of which kinds of wireless fixed position jointly. Still point out at the same time, although all and wireless equipment has its advantage and drawback, but when should involving mammary pathological change, they are good to the position result expression of alar lymph node.